iGlarLixi vs. Basal-Bolus (BB) or Premixed Insulin in Older Adult Ethnic Minorities with Type 2 Diabetes (T2D)

被引：0
|
作者：
Umpierrez, Guillermo
Gill, Jasvinder
Hood, David
Li, Xuan
Nunez, Ana
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-829-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
829-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Treatment persistence, adherence and healthcare resource utilisation for iGlarLixi versus basal-bolus insulin or premixed insulin in older adult ethnic minorities with type 2 diabetes: SoliEthnicity study
    Umpierrez, Guillermo
    Gill, Jasvinder
    Hood, David
    Li, Xuan
    Nunez, Ana
    DIABETES OBESITY & METABOLISM, 2024,
  • [2] Initiation of iGlarLixi vs. Basal-Bolus Insulin (BB) in Adults with Type 2 Diabetes (T2D) Advancing from Basal Insulin (BI) Therapy: The SoliComplex Real-World Study
    Pantalone, Kevin M.
    Heller, Caroline
    Lajara, Rosemarie
    Lew, Elisheva
    Li, Xuan
    Dex, Terry A.
    Kilpatrick, Rachel
    DIABETES, 2022, 71
  • [3] Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) vs. Basal-Bolus (BB) Therapy in Patients with Type 2 Diabetes (T2D): DUAL VII Trial
    Billings, Liana K.
    Doshi, Ankur
    Gouet, Didier
    Oviedo, Alejandra
    Rodbard, Helena W.
    Tentolouris, Nikolaos
    Gron, Randi
    Halladin, Natalie
    Jodar, Esteban
    DIABETES, 2017, 66 : A36 - A36
  • [4] iGlarLixi vs. Premixed Insulin Initiation in Adults with Type 2 Diabetes (T2D) Advancing from Basal Insulin (BI) Therapy: SoliComplex Real-World Study
    Lajara, Rosemarie
    Heller, Caroline
    Pantalone, Kevin M.
    Lew, Elisheva
    Li, Xuan
    Dex, Terry A.
    Kilpatrick, Rachel
    DIABETES, 2022, 71
  • [5] Patient-Reported Outcomes (PROs) in Insulin Degludec/Liraglutide (IDegLira) vs. Basal-Bolus (BB) Therapy in Patients (Pts) with Type 2 Diabetes (T2D): DUAL VII Trial
    Billings, Liana K.
    Doshi, Ankur
    Gouet, Didier
    Oviedo, Alejandra
    Rodbard, Helena W.
    Tentolouris, Nikolaos
    Kirstine Busk, Anne
    Basse, Amaury
    Jodar, Esteban
    DIABETES, 2017, 66 : LB32 - LB32
  • [6] Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    Umpierrez, Guillermo E.
    DIABETES CARE, 2015, 38 (12) : 2211 - 2216
  • [7] Diabetes-related outcomes with basal-bolus vs. premixed insulin among veterans with type 2 diabetes: A single institutional retrospective study
    Bai, Ravisha
    Batra, Kavita
    Yap, Charmaine
    Izuora, Kenneth
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 366 (01): : 38 - 43
  • [8] Treatment Patterns and Characteristics of Patients with Type 2 Diabetes (T2D) Managed with Basal-Bolus Therapy in the
    Van Brunt, Kate
    Curtis, Bradley H.
    Chalkiadaki, Corina
    Balogh, Elemer
    Ivanyi, Tibor
    Raluy, Mireia
    Maclachlan, Sharon
    DIABETES, 2015, 64 : A696 - A697
  • [9] A comparison of prandial premixed (ILPS/lispro) vs basal bolus (glargine/lispro) insulin therapy in obese patients with type 2 diabetes (T2D)
    Ahmann, Andrew
    Jiang, Honghua
    Martin, Sherry A.
    DIABETES, 2008, 57 : A564 - A564
  • [10] Efficacy and safety of prandial premixed (ILPS/lispo) vs basal bolus (glargine/lispro) insulin therapy in Hispanic and African American patients with type 2 diabetes (T2D)
    Colon, Gildred
    Jiang, Honghua
    Martin, Sherry A.
    DIABETES, 2008, 57 : A143 - A144
12345